Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Hedge Fund MSMB Offers to Buy AMAG For $381M and Thwart Proposed Allos Merger

Aug 03 2011

• By The Pink Sheet Daily

Related Content

AMAG Pharmaceuticals: Enough Irons In The Fire?

May 01 2010

Chronic Kidney Disease Drug Developers Jockey For Position In Era Of Change

Dec 01 2010

Investors Balk At AMAG-Allos Proposed Marriage

Jul 20 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window